Discover why Merck presents a compelling long-term investment opportunity with its discounted valuation, robust pipeline, and ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...

Merck & Co Inc (MRK) stock saw a decline, ending the day at $96.24 which represents a decrease of $-1.68 or -1.72% from the prior close of $97.92. The stock opened at $98.08 and touched a low of ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $99.25 which represents a decrease of $-0.60 or -0.60% from the prior close of $99.85. The stock opened at $99.21 and touched a ...

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a ...

We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and ...

Key Takeaways Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck ...

The U.S. consumer prices report released this week revealed ... We believe investors with a long-term horizon should hold MRK stock, while short-term investors should consider selling it.